NEPHROS INC (NEPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5M 5M 7.5M Q3 '16: 475K Q4 '16: 745K Q1 '17: 734K Q2 '17: 859K Q3 '17: 916K Q4 '17: 1.3M Q1 '18: 985K Q2 '18: 1.4M Q3 '18: 1.7M Q4 '18: 1.6M Q1 '19: 1.8M Q2 '19: 2.3M Q3 '19: 3.1M Q4 '19: 3.2M Q1 '20: 2.5M Q2 '20: 1.6M Q3 '20: 2.1M Q4 '20: 2.3M Q1 '21: 2.7M Q2 '21: 2.3M Q3 '21: 2.6M Q4 '21: 2.7M Q1 '22: 2.2M Q2 '22: 2.9M Q3 '22: 2.4M Q4 '22: 2.6M Q1 '23: 3.7M Q2 '23: 3.5M Q3 '23: 3.7M Q4 '23: 3.3M Q1 '24: 3.5M Q2 '24: 3.3M Q3 '24: 3.5M Q4 '24: 3.9M Q1 '25: 4.9M Q2 '25: 4.4M Q3 '25: 4.8M Q4 '25: 4.7M Q1 '26: 5.2M Q2 '26: 6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 1.5M 3M 4.5M Q3 '16: 316K Q4 '16: 386K Q1 '17: 455K Q2 '17: 517K Q3 '17: 532K Q4 '17: 788K Q1 '18: 467K Q2 '18: 830K Q3 '18: 952K Q4 '18: 954K Q1 '19: 998K Q2 '19: 1.4M Q3 '19: 1.8M Q4 '19: 1.9M Q1 '20: 1.5M Q2 '20: 895K Q3 '20: 1.2M Q4 '20: 1.3M Q1 '21: 1.6M Q2 '21: 1.3M Q3 '21: 1.4M Q4 '21: 1.5M Q1 '22: 1.1M Q2 '22: 1.4M Q3 '22: 762K Q4 '22: 1.5M Q1 '23: 2.1M Q2 '23: 2.1M Q3 '23: 2.2M Q4 '23: 2M Q1 '24: 2.2M Q2 '24: 1.9M Q3 '24: 2.1M Q4 '24: 2.5M Q1 '25: 3.2M Q2 '25: 2.8M Q3 '25: 2.9M Q4 '25: 2.8M Q1 '26: 3M Q2 '26: 4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '16: -637K Q4 '16: -609K Q1 '17: -605K Q2 '17: -700K Q3 '17: -518K Q4 '17: -403K Q1 '18: -1.1M Q2 '18: -653K Q3 '18: -511K Q4 '18: -729K Q1 '19: -1.3M Q2 '19: -868K Q3 '19: -695K Q4 '19: -291K Q1 '20: -1M Q2 '20: -1.6M Q3 '20: -932K Q4 '20: -719K Q1 '21: -1M Q2 '21: -1.1M Q3 '21: -802K Q4 '21: -721K Q1 '22: -1.5M Q2 '22: -814K Q3 '22: -1.3M Q4 '22: -693K Q1 '23: -306K Q2 '23: -435K Q3 '23: -203K Q4 '23: -649K Q1 '24: -200K Q2 '24: -317K Q3 '24: 206K Q4 '24: 317K Q1 '25: 566K Q2 '25: 248K Q3 '25: 314K Q4 '25: 18K Q1 '26: 97K Q2 '26: 1.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '16: -706K Q4 '16: -655K Q1 '17: -680K Q2 '17: -786K Q3 '17: -632K Q4 '17: 1.3M Q1 '18: -1.4M Q2 '18: -682K Q3 '18: -566K Q4 '18: -725K Q1 '19: -1.3M Q2 '19: -942K Q3 '19: -744K Q4 '19: -144K Q1 '20: -1.1M Q2 '20: -1.7M Q3 '20: -1M Q4 '20: -759K Q1 '21: -537K Q2 '21: -1.1M Q3 '21: -1.2M Q4 '21: -863K Q1 '22: -2M Q2 '22: -1.1M Q3 '22: -3.2M Q4 '22: -848K Q1 '23: -306K Q2 '23: -433K Q3 '23: -182K Q4 '23: -654K Q1 '24: -169K Q2 '24: -289K Q3 '24: 183K Q4 '24: 349K Q1 '25: 558K Q2 '25: 237K Q3 '25: 337K Q4 '25: 62K Q1 '26: 140K Q2 '26: 1.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 800K 1.6M 2.4M Q1 '17: 279K Q2 '17: 342K Q3 '17: 384K Q4 '17: 512K Q1 '18: 518K Q2 '18: 536K Q3 '18: 772K Q4 '18: 658K Q1 '19: 771K Q2 '19: 942K Q3 '19: 1.3M Q4 '19: 1.3M Q1 '20: 1M Q2 '20: 682K Q3 '20: 896K Q4 '20: 1M Q1 '21: 1.1M Q2 '21: 991K Q3 '21: 1.2M Q4 '21: 1.2M Q1 '22: 1.1M Q2 '22: 1.5M Q3 '22: 1.6M Q4 '22: 1M Q1 '23: 1.6M Q2 '23: 1.5M Q3 '23: 1.5M Q4 '23: 1.2M Q1 '24: 1.3M Q2 '24: 1.3M Q3 '24: 1.4M Q4 '24: 1.4M Q1 '25: 1.7M Q2 '25: 1.6M Q3 '25: 1.8M Q4 '25: 2M Q1 '26: 2.2M Q2 '26: 2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q2 '16: -272K Q3 '16: -790K Q4 '16: -528K Q1 '17: -659K Q2 '17: -499K Q3 '17: -713K Q4 '17: 1.8M Q1 '18: -669K Q2 '18: -1.3M Q3 '18: -1.1M Q4 '18: -528K Q1 '19: -697K Q2 '19: -1.3M Q3 '19: -614K Q4 '19: 364K Q1 '20: -1.8M Q2 '20: -1.7M Q3 '20: -1.8M Q4 '20: -1.5M Q1 '21: -55K Q2 '21: -117K Q3 '21: -910K Q4 '21: -335K Q1 '22: -1.8M Q2 '22: -1.1M Q3 '22: -170K Q4 '22: -195K Q1 '23: 276K Q2 '23: 226K Q3 '23: 562K Q1 '24: -672K Q2 '24: -501K Q3 '24: -623K Q4 '24: 1.3M Q1 '25: 322K Q2 '25: 994K Q3 '25: 99K Q4 '25: 230K Q1 '26: -1.7M Q2 '26: 681K Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q4 '10: -675K Q3 '12: -717K Q4 '12: -459K Q1 '16: -548K Q2 '16: -286K Q3 '16: -795K Q4 '16: -528K Q4 '19: 364K Q3 '20: -1.8M Q4 '20: -1.5M Q1 '21: -78K Q2 '21: -117K Q3 '21: -923K Q4 '21: -335K Q1 '22: -1.8M Q2 '22: -1.2M Q3 '22: -170K Q4 '22: -195K Q3 '24: -623K Q4 '24: 1.3M Q3 '12 Q2 '16 Q4 '19 Q1 '21 Q4 '21 Q3 '22 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '13: 17.6M Q1 '14: 18.8M Q2 '14: 25.2M Q3 '14: 33.5M Q1 '15: 37.1M Q2 '15: 31.2M Q3 '15: 32.6M Q1 '16: 48.2M Q2 '16: 48.5M Q1 '21: 9.9M Q2 '21: 9.9M Q3 '21: 10M Q1 '22: 10.2M Q2 '22: 10.3M Q3 '22: 10.3M Q1 '23: 10.3M Q2 '23: 10.3M Q3 '23: 10.5M Q1 '24: 10.5M Q2 '24: 10.5M Q3 '24: 10.6M Q1 '25: 10.6M Q2 '25: 10.8M Q3 '25: 11M Q1 '26: 11M Q2 '26: 11.1M Q1 '14 Q2 '15 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q3 '16: -0.07 Q4 '16: -0.06 Q1 '17: -0.05 Q2 '17: -0.04 Q3 '17: -0.04 Q4 '17: -0.02 Q1 '18: -0.04 Q2 '18: -0.13 Q3 '18: -0.20 Q4 '18: -0.31 Q1 '19: -0.48 Q2 '19: -0.52 Q3 '19: -0.54 Q4 '19: -0.46 Q1 '20: -0.39 Q2 '20: -0.44 Q3 '20: -0.46 Q4 '20: -0.52 Q1 '21: -0.45 Q2 '21: -0.38 Q3 '21: -0.38 Q4 '21: -0.41 Q1 '22: -0.55 Q2 '22: -0.55 Q3 '22: -0.74 Q4 '22: -0.73 Q1 '23: -0.56 Q2 '23: -0.48 Q3 '23: -0.19 Q4 '23: -0.15 Q1 '24: -0.14 Q2 '24: -0.13 Q3 '24: -0.09 Q4 '24: 0.01 Q1 '25: 0.08 Q2 '25: 0.13 Q3 '25: 0.14 Q4 '25: 0.11 Q1 '26: 0.07 Q2 '26: 0.16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.